Journal
ANIMAL CELLS AND SYSTEMS
Volume 20, Issue 6, Pages 344-352Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/19768354.2016.1250817
Keywords
SLPI; inflammation; alveolar bone; MC3T3-E1; periodontitis
Categories
Funding
- Health Fellowship Foundation
Ask authors/readers for more resources
In periodontitis, alveolar bone resorption is induced by excessive host immune and inflammatory response against bacterial infection. Secretory leukocyte protease inhibitor (SLPI) has antibacterial and anti-inflammatory activity in inflammatory responses. SLPI inhibits joint inflammation and bone destruction, but the function of SLPI in periodontitis is unclear. Therefore, this study investigated whether SLPI inhibits the inflammatory response and alveolar bone resorption in LPS-induced periodontitis of rats. Micro-computed tomography and histological analysis showed that SLPI inhibited alveolar bone resorption by LPS-induced periodontitis. Immunohistochemistry revealed that SLPI decreased tumor necrosis factor-alpha (TNF-alpha) and interleukine-1 beta (IL-1 beta) expression in periodontitis tissue, and decreased mRNA and protein expression of TNF-alpha and IL-1 beta in LPS-stimulated MC3T3-E1 cells. The results indicated that SLPI reduced alveolar bone resorption in LPS-induced periodontitis and inhibited inflammatory cytokine, such as TNF-alpha and IL-1 beta, expression in LPS-stimulated MC3T3-E1 preosteoblasts. Therefore, SLPI could be a regulatory molecule by inhibiting alveolar bone resorption through the reduction of inflammatory cytokines, and inducing osteoblast activation for bone formation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available